top of page

ADHD

Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder.

Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat–an animal model of attention deficit hyperactivity disorder.

Cannabis improves symptoms of ADHD.

Drug Reinforcement in a Rat Model of Attention Deficit/Hyperactivity Disorder – The Spontaneously Hypertensive Rat (SHR)

Methods of the Pharmacological Imaging of the Cannabinoid System (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition.

Alzheimer's Disease

A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology.

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease.

Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.

​Cannabinoids for the treatment of dementia.

​Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.

​Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.

​Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview.

Synthetic Cannabinoids in Dementia with Agitation: Case Studies and Literature Review.

The influence of cannabinoids on generic traits of neurodegeneration.

The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease.

Antioxidant

Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants.

Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress

Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure

Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy

Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy

Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver

Neuroprotective antioxidants from marijuana

Oxyradical Stress, Endocannabinoids, and Atherosclerosis

Prospects for cannabinoid therapies in basal ganglia disorders

Protective effects of Δ9-tetrahydrocannabinol against N-methyl-Daspartate-induced AF5 cell death

Anxiety

Action of cannabidiol on the anxiety and other effects .produced by delta 9-THC in Normal Subjects.

Antidepressant-like and anxiolytic-like effects of Cannabidiol: a chemical compound of Cannabis sativa.

Cannabinoid-related Agents in the Treatment of Anxiety.

Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug

Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA (A) receptors.

Distinct effects of Delta9-Tetrahydrocannabinol mainly modulated activation in frontal and parietal areas.

Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow

Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.

Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice.

Autism

Alterations in the endocannabinoid system in the rat valproic acid model of autism.

Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling.

Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders.

Consequences of Cannabinoid and Monoaminergic System Disruption in a Mouse Model of Autism Spectrum Disorders.

Deficient Social and Play Behavior in Juvenile and Adult Rats after Neonatal Cortical Lesion: Effects of Chronic Pubertal Cannabinoid Treatment.

​Endocannabinoid System as Novel Therapeutic Target for Autism Treatment.

Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression.

Species differences in cannabinoid receptor 2 (CNR2gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands.

Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome.

Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child.

Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces.

Autoimmune

An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia.

Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice.

​Cannabidiol arrests onset of autoimmune diabetes in NOD mice.

Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?

Cannabis Use in Fibromyalgia.

​Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based investigation.

Emerging role of the cannabinoid receptor CB2in immune regulation: therapeutic prospects for neuroinflammation.

Endocannabinoids and immune regulation.

Endocannabinoids and the Immune System in Health and Disease.

Endocannabinoid system acts as a regulator of immune homeostasis in the gut.

Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly.

​Medical cannabis: A forward vision for the clinician.

Medical Cannabis for the Treatment of Fibromyalgia.

Safety and Efficacy of Medical Cannabis in Fibromyalgia.

Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges.

The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.

bottom of page